Docstoc

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Pharmasset, Inc

Document Sample
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Pharmasset, Inc Powered By Docstoc
					
				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:2
posted:11/22/2011
language:English
pages:2
Description: NEW YORK--(EON: Enhanced Online News)--Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors of Pharmasset, Inc. (“Pharmasset” or the “Company”) (NASDAQ: VRUS) concerning the proposed acquisition of Pharmasset by Gilead Sciences, Inc. in a cash transaction valued at $11 billion. The investigation concerns whether the board of directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value. Under the terms a style='font-size:
EON: Enhanced Online News EON: Enhanced Online News http://eon.businesswire.com
About At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.